RxDoctor Payments Data

Evan Vogel, MD

Psychiatry · Greenville, SCNPI 1235143066

Payments from drug & device makers

$2,299in general payments, 2019–2025

Across 142 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$588
  • Otsuka America Pharmaceutical, Inc.$349
  • Neurocrine Biosciences, Inc.$252
  • AbbVie$239
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$197
  • Alkermes, Inc.$173
  • plus $501 from 9 others

What the payments were for

  • Food & beverage$2,18995%
  • Education$1115%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,299 in reported general payments places this provider in the 75th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Medicare billing

Part B allowed, 2024
$16,346
Medicare patients
52
Services billed
199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate100$296,044
AustedoDeutetrabenazine24$226,791
Abilify MaintenaAripiprazole15$43,083
AristadaAripiprazole Lauroxil14$42,001
RexultiBrexpiprazole17$24,052
SaphrisAsenapine Maleate21$22,577
Lurasidone Hcl39$14,823
TrintellixVortioxetine Hydrobromide18$9,981
Paliperidone ErPaliperidone46$7,296
Ziprasidone Hcl53$3,653
Quetiapine Fumarate239$3,321
Aripiprazole52$2,220
Divalproex Sodium ErDivalproex Sodium60$2,114
Benztropine Mesylate112$2,044
Venlafaxine Hcl ErVenlafaxine Hcl113$1,827

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$168$296,044100 claims
Teva Pharmaceuticals USA, Inc.Austedo, Loxapine$588$228,10056 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$349$67,13432 claims
Alkermes, Inc.Aristada$173$42,00114 claims
AbbVieSaphris$239$22,57721 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$39$9,98118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →